Search - tctmd.com

Displaying 101 - 120 of 157

Sort: Relevancy | Date

News Conference News ACC 2016

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

Michael O'Riordan

April 04, 2016

News Daily News

研究表明，非罪犯血管血运重建可改善STEMI患者健康状况

Todd Neale

November 04, 2015

News Daily News

Un Estudio Sugiere que la Revascularización de Arterias No Causantes Mejora el Estado de Salud de Pacientes STEMI

Todd Neale

November 04, 2015

News Daily News

Study Suggests Nonculprit Revascularization Enhances Health Status of STEMI Patients

Todd Neale

November 04, 2015

Presentation TCT 2015

First-in-Man Experience With Human Embryonic Stem Cell-Derived Progenitors for Heart Failure

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Philippe Menasché

October 15, 2015

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? For Limb Ischemia There Are Knowns and Unknowns!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Amit Patel

October 15, 2015

$Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!$

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? Yes, Mesenchymal Cells Are Ready to Be Tested for Prevention and Treatment of Chronic Ischemic and Nonischemic Heart Failure!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Emerson C. Perin

October 15, 2015

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? Yes, in STEMI Bone Marrow Mononuclear Fraction Is Ready, and Other Options Are Coming!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Ricardo Sanz-Ruiz

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

Presenter: Nabil Dib, Philippe Menasché, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

Disappointing Clinical Trial Experiences to Date: Should We Continue? In Which Setting? How?

Presenter: Francisco Fdez-Aviles, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

Stem Cells in Biology of the Adult Myocardium: Are Biomaterials the Missing Link?

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Jay H Traverse

October 15, 2015

Presentation TCT 2015

Cell-Based Therapies to Prevent and Cure Heart Failure: More Than an Adventure

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Douglas W. Losordo

October 15, 2015

$Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina$

Presentation TCT 2015

Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina

Presenter: Greg L. Kaluza, Joachim Schofer, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

Cell Therapy for CHF

Presenter: Henricus J. Duckers, Bernard J. Gersh, Timothy D. Henry

October 14, 2015

Presentation TCT 2015

TCTMD Global PCI Mapping Project: Description and Goals

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Ivan C. Rokos

October 11, 2015

Presentation TCT 2015

Improving Door-in-Door-out in STEMI Transfer: The Last Frontier

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Christopher B. Granger

October 11, 2015

Presentation TCT 2015

Telemedicine and Artificial Intelligence to Optimize STEMI Outcomes: The Brazil Experience

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Roberto Botelho

October 11, 2015

Presentation TCT 2015

Is Deferred Stenting an Option? Rationale for the DEFER-STEMI Trial

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Colin Berry

October 11, 2015

Presentation TCT 2015

A Fresh Look at the Pharmacoinvasive Strategy

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Eric R. Bates

October 11, 2015

Advertisement

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

研究表明，非罪犯血管血运重建可改善STEMI患者健康状况

Un Estudio Sugiere que la Revascularización de Arterias No Causantes Mejora el Estado de Salud de Pacientes STEMI

Study Suggests Nonculprit Revascularization Enhances Health Status of STEMI Patients

First-in-Man Experience With Human Embryonic Stem Cell-Derived Progenitors for Heart Failure

Debate: Are We Really Ready for Phase III Trials? For Limb Ischemia There Are Knowns and Unknowns!

Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!

Debate: Are We Really Ready for Phase III Trials? Yes, Mesenchymal Cells Are Ready to Be Tested for Prevention and Treatment of Chronic Ischemic and Nonischemic Heart Failure!

Debate: Are We Really Ready for Phase III Trials? Yes, in STEMI Bone Marrow Mononuclear Fraction Is Ready, and Other Options Are Coming!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

Disappointing Clinical Trial Experiences to Date: Should We Continue? In Which Setting? How?

Stem Cells in Biology of the Adult Myocardium: Are Biomaterials the Missing Link?

Cell-Based Therapies to Prevent and Cure Heart Failure: More Than an Adventure

Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina

Cell Therapy for CHF

TCTMD Global PCI Mapping Project: Description and Goals

Improving Door-in-Door-out in STEMI Transfer: The Last Frontier

Telemedicine and Artificial Intelligence to Optimize STEMI Outcomes: The Brazil Experience

Is Deferred Stenting an Option? Rationale for the DEFER-STEMI Trial

A Fresh Look at the Pharmacoinvasive Strategy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content